Refractory warts: topical or intralesional cidofovir options

Published Date: 02 Mar 2023

New research suggests that cidofovir may be a helpful option for tender joints or joints.

Read Full News

Latest News

Secukinumab Gets FDA Nod for Adolescent HS

Weight-based injectable’s approval is based in part on other pediatric indications.

HSV-1 May Be Increasing in Infants

A new study suggests that HSV-1 has become the dominant subtype among newborns.

Low-Beta Radiation Patch Offers Alternative NMSC Treatment

Similar to brachytherapy, OncoPatch could be an option for patients who have superficial lesions or who aren’t surgical candidates.

UK Approves New JAK Inhibitor for Severe Alopecia

Deuruxolitinib is the latest JAK inhibitor to enter the UK alopecia areata treatment landscape, pending a NICE decision on NHS access.

What Does FDA Food Pyramid Mean for Cancer Risk and Care?

Much of the new FDA food guidance aligns with existing advice, but some areas may introduce confusion to advising patients on diet and cancer prevention and survival.

Tildrakizumab Now Under FDA Review for Psoriatic Arthritis

Full results from the pivotal trials submitted to support approval have not yet been reported.

Todays Updates

LAIs vs Oral Antipsychotics for Bipolar I Rehospitalization

Long-acting injectable antipsychotics are linked to lower rehospitalization rates than oral antipsychotics in patients with bipolar I disorder, a study shows.

MRI-Guided TULSA Speeds Recovery vs Robotic Prostatectomy

The CAPTAIN trial shows faster recovery, fewer complications, and better early function with the minimally invasive therapy in men with intermediate-risk prostate cancer.

Todays Updates

LAIs vs Oral Antipsychotics for Bipolar I Rehospitalization

Long-acting injectable antipsychotics are linked to lower rehospitalization rates than oral antipsychotics in patients with bipolar I disorder, a study shows.

MRI-Guided TULSA Speeds Recovery vs Robotic Prostatectomy

The CAPTAIN trial shows faster recovery, fewer complications, and better early function with the minimally invasive therapy in men with intermediate-risk prostate cancer.

Latest News

Weight-based injectable’s approval is based in part on other pediatric indications.

A new study suggests that HSV-1 has become the dominant subtype among newborns.

Similar to brachytherapy, OncoPatch could be an option for patients who have superficial lesions or who aren’t surgical candidates.

Deuruxolitinib is the latest JAK inhibitor to enter the UK alopecia areata treatment landscape, pending a NICE decision on NHS access.

Much of the new FDA food guidance aligns with existing advice, but some areas may introduce confusion to advising patients on diet and cancer prevention and survival.

Full results from the pivotal trials submitted to support approval have not yet been reported.

News All Time

Healthy Diet May Cut Cancer Survivors’ Premature Aging Risk

A recent study found reduced premature aging among childhood cancer survivors that adhered to established dietary guidelines.

AI Tools Helpful With Prior Auth Letters, Handouts, and More

‘Specify everything you need, do it as if you’re talking to your medical assistant,’ one dermatologist recommends.

Study Identifies Factors Linked to Early Melanoma Recurrence

Several clinicopathologic features beyond tumor thickness and ulceration are associated with recurrence risk in patients with localized stage I-II melanoma.

Antimalarials May Cut RA and SLE Hospital Admissions, Stays

Patients with RA or SLE who adhere to antimalarial therapy have a lower risk for hospital admission and fewer days of hospital stay than their nonadherent peers.

Can Fecal Transplants Enhance Immunotherapy? New Evidence

Fecal microbiota transplants may enhance patients’ response to immunotherapy, but experts caution that the latest data remain proof-of-concept and far from practice-changing.

Expert Meeting on US Measles Elimination Status Delayed to November

A meeting of an international panel of experts that was set to review the United States' measles ⁠elimination status next month has been postponed until November, the Pan...

Melanoma Cases Top Skin Cancer Lawsuits

A review finds melanoma accounts for nearly half of skin cancer malpractice cases, with delayed diagnosis being the leading allegation.

CSF Biomarkers Suggest Impact of Herpes on Brain Health

Biomarkers for Alzheimer’s disease are linked to latent infection in people with HIV.

MHRA Clears Brensocatib for Bronchiectasis

The MHRA has licensed brensocatib as the first disease-specific therapy for non-cystic fibrosis bronchiectasis in patients with recurrent exacerbations.

Bimekizumab Improves Hidradenitis Suppurativa Severity

Bimekizumab yields clinically meaningful improvements in the severity of hidradenitis suppurativa over 48 weeks, shifting most patients to a mild disease, a pooled analysis of two trials shows.

Americans Trust Vaccines, School Mandates, Rejecting Trump Agenda, Reuters/Ipsos Poll Finds

A bipartisan majority of Americans believe vaccines are safe and that children should receive them to attend school, according to a new Reuters/Ipsos poll, illustrating the...

New Mental Health Disorders Tied to Early Cancer Mortality

In a decade-long analysis of University of California health system data, researchers assess early-onset mental health disorders after cancer diagnosis and subsequent survival trends.

NHS to Fund Ruxolitinib for Vitiligo

NICE has recommended topical ruxolitinib for facial non-segmental vitiligo in patients aged 12 or over after a revised cost review.

Lipedema Is Now Recognized as a Chronic Disease

International consensus defines lipedema as a chronic disease; clarifies its biology and diagnosis; and urges standardized care, research, and policy action.

Lilly's Zepbound and Taltz Improve Psoriasis Symptoms, Drive Weight Loss in Study

Eli Lilly said on Wednesday its weight-loss drug, Zepbound, used with psoriasis treatment Taltz, showed ⁠better results in patients with the skin disease and obesity in a...

Recommended News For You

Blood tests can predict the risk of relapse after a bone marrow transplant in patients with acute myeloid leukemia.

Large, Grade 4 Kidney Tumors Pose Risk of Early Cancer-Specific Mortality

Acalabrutinib + Venetoclax Combo Earns FDA Nod for CLL

Testosterone recovery linked to overall survival in high-risk prostate cancer

Prostate cancer screening seems to be improved by PSA, biomarker testing, and MRI combined.

Drugmaker Pulls Trodelvy's Bladder Cancer Approval

Progress in Early Cancer Diagnosis; Breast Cancer in Younger Women; Diet and Cancer.

Recommended Articles For You

Ear Emergency: Understanding the Causes and Treatment for Auricular Hematoma 

General Practitioners Role in Diagnosing Ovarian Cancer 

Cancer Stem Cells: The Seeds of Tumorigenesis and Recurrence 

What You Need to Know About the Early Warning Signs of Colon Cancer  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Charles III, King of Kings, is Cancerous.

2.

Males with early-onset colorectal cancer are at risk, according to a study.

3.

Targeted radiation therapy shows near-complete response in rare sarcoma patients

4.

Artificial intelligence is assisting in the earlier detection and treatment of breast cancer.

5.

Trial Questions Role of Dual Immunotherapy in First-Line NSCLC

1.

Unlocking the Potential of Polatuzumab for Cancer Treatment

2.

Lymphomatoid Papulosis: What You Need to Know

3.

Integrative Cancer Care: Nutrition, Social Work, Care Coordination, and Genetic Counseling

4.

Revolutionizing Cancer Treatment: Advances in Immunotherapy and Cell Therapy

5.

Innovative Bioengineering Approaches for Erectile Function Recovery After Radical Prostatectomy

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

From Relapse to Remission : Chasing the Invisible and Redefining Long-Term Survival in Adult R/R B-Cell ALL

2.

Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment

3.

Navigating the Complexities of Ph Negative ALL - Part V

4.

Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer

5.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot